Revealed: Shocking number of deaths linked to weight loss jabs...as health chiefs issue chilling alert about organ-destroying side effect
More than 100 deaths in Britain have now been linked to blockbuster weight loss jabs, official data shows.
Two of the victims were people in their 20s, according to a MailOnline analysis of logs kept by the medicine safety watchdog.
Of the 107 fatalities reported by doctors and patients, the vast majority involve slimming jabs approved within the last few years, such as Mounjaro and Ozempic.
The findings come as the Medicines and Healthcare Products Regulatory Agency (MHRA)confirmed that at least 10 people in the UK using the injections had died from pancreatitis; a life-threatening inflammation of the pancreas.
Officials announced last night that they are now investigating if the condition is more likely to strike some patients with specific genes.
It comes just months after the death of 58 year-old Scottish nurse Susan McGowan who suffered multiple organ failure, septic shock and pancreatitis after just two doses of Mounjaro—the so-called 'King Kong' of weight loss jabs.
Ms McGowan is currently the only named fatality linked to the jabs in the UK.
However, medics have told of a wave young women requiring life-saving A&E treatment after obtaining the drugs privately from online pharmacies.
In the majority of these cases, the victims had no weight-related health problems but were using the drugs for cosmetic reasons. Some were not even overweight.
Of the 107 deaths recorded by the MHRA the majority were linked to a weight-loss jab called liraglutide, with 37 fatalities since 2010.
This drug—sold under the brand Saxenda—works similar to the more famous brands Wegovy and Mounjaro and is approved as a weight loss drug in the UK.
The vast majority of fatalities linked to the drug were among the over 50s, though two were recorded in patients in their 20s.
Semaglutide—the active ingredient in Ozempic and Wegovy—and tirzepatide, sold as Mounjaro, had an equal number of linked fatalities with 30 apiece.
However, Mounjaro has reached this total much faster, with 30 reports linking it to deaths in just a year-and-half.
Semaglutide has taken five-and-half-years to reach this number of linked fatalities.
Mounjaro has been dubbed the 'King Kong' of weight loss jabs due to its potency, helping people lose up to a fifth of their body weight in a year.
Twelve other deaths were recorded for similar drugs—collectively known as 'GLP-1' injections—but which are approved solely for use in treating diabetes.
Weight loss injections work by mimicking natural appetite suppressing hormones to make people feel fuller, helping them lose weight.
All deaths were logged under the Medicines and Healthcare products Regulatory Agency (MHRA) 'Yellow Card' scheme.
The system—set-up in the wake of the 1960s thalidomide scandal—allows officials to track potential adverse reactions to medications approved for use in the UK and spot emerging patterns.
Every drug approved for us in the UK has to go through safety trials before being made available to the public.
But there is an unavoidable risk that rare reactions or interactions with other illnesses and conditions may have been missed, which is where the Yellow Card system comes in.
If a worrying pattern emerges it can lead to drugs' approval being reviewed, having new warnings added to the labels or the medication potentially being taken off the market completely.
As anyone can use the system—patients as well as their medics—a death being linked to a specific drug is not proof it was responsible.
The MHRA highlights that some reactions—including fatal ones—may simply be coincidence.
For example, a patient taking a weight loss jab may experience a fatal heart attack, but the event may have nothing to do with the drug they were taking at the time.
Last night the MHRA said it had received more than 560 reports of patients developing an inflamed pancreas from taking GLP-1 injections since they first launched.
While these drugs are frequently used for weight management, some like Ozempic are primarily licensed for the treatment of type 2 diabetes.
Of the 10 linked pancreatitis fatalities, five were connected to Mounjaro.
Scientists aren't completely clear on why GLP-1 drugs can trigger deadly pancreatitis.
However, experts suspect the reaction is caused by how the drugs interact with the pancreas by triggering it to release the hormone insulin, helping to stabilise blood sugars.
Scientists say in some cases this may 'overstimulate' cells in the organ—putting excess strain on it—and causing the pancreas to become severely inflamed.
The MHRA is now calling for users who are admitted to hospital with pancreatitis to report the side effect to authorities using the regulator's Yellow Card scheme.
Healthcare workers can also submit a report on patients' behalf.
Such patients will then be contacted by the MHRA to ask them to take part in a new study, to see if they have a gene that makes them at higher risk of pancreatitis while taking the drugs.
The ultimate aim is to create a test that will enable medics to find if a patient has these pancreatitis-risk genes before they prescribe the drugs.
Patient safety leaflets distributed with Ozempic, Wegovy, Mounjaro and Saxenda all acknowledge pancreatitis as a potential rare reaction to taking the drug.
The main symptom of pancreatitis is severe pain in the stomach that radiates to the back and does not go away.
Anyone who experiences this should seek immediate medical help.
Ms McGowan—the only named fatality from using weight loss jabs in the UK—took Mounjaro, for a two-week period before her death on September 4 last year.
Just days after taking the drug, she started having severe stomach pains and went to A&E at the hospital she worked at, University Hospital Monklands in Airdrie, Scotland.
Although her colleagues fought to save her, she died shortly after.
Her death certificate listed multiple organ failure, septic shock and pancreatitis as the immediate cause of death but added the prescribed use of tirzepatide as a factor.
The MHRA's announcement comes a day after experts issued guidance to GPs to look for two life-threatening conditions that can be triggered by weight loss jabs acute pancreatitis and biliary disease.
The advice tells doctors to look for signs of two life-threatening conditions that can be triggered by the drugs—acute pancreatitis and biliary disease.
Warnings over the potential side effects of taking weight-loss jabs come just as the Government makes it easier for Britons to take them.
From this week patients in England this week will be able Mounjaro, through their family doctor for the first time.
The weekly injection will be offered to around 220,000 people over the next three years under the new NHS prescribing rules.
Under previous regulations patients could only access Mounjaro on the NHS via a limited number of specialist weight loss clinics ran by the health service.
Recent estimates suggest that about 1.5 million people in the UK are taking weight loss jabs, many of which are bought privately due to NHS rationing.
Health officials have suggested that they can help to turn the tide on obesity but have stressed they are not a silver bullet and do come with side effects.
Most side effects linked to the jabs are gastrointestinal including nausea, constipation and diarrhoea.
However, the medical regulator recently warned that Mounjaro may make the oral contraceptive pill less effective in some patients.
A spokesperson for Lilly UK, the makers of Mounjaro, reacting to reports of deaths linked to the drug said patient safety is its 'top priority'.
They added: 'Regulatory agencies conduct extensive independent assessments of the benefits and risks of every new medicine and Lilly is committed to continually monitoring, evaluating, and reporting safety data.'
'If anyone is experiencing side effects when taking any Lilly medicine, they should talk to their doctor or other healthcare professional.'
In the US, nearly 200 deaths have been linked to weight loss jabs.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
an hour ago
- Daily Mail
Doctor who led British Medical Association's opposition to kids' puberty blocker ban elected as its new leader
The doctor who spearheaded the British Medical Association's opposition to the UK's puberty blocker ban has been elected as its new leader. Dr Tom Dolphin tabled the motion that led to the union controversially lobbying against the findings of the Cass Review into children's gender services. The BMA's governing council sparked fury in July last year when it voted to 'critique' the work, without consulting wider members. This set the BMA apart from the NHS, government and other leading medical organisations who universally backed the study, which took four years to complete and reviewed data from 113,000 children. Key among the recommendations was a ban on prescribing sex hormones to trans-identifying children outside of clinical trials. Critics described the BMA meeting where the vote took place as 'secretive and opaque'. The same council, consisting of 69 members, this week voted to oust sitting chair Professor Phil Banfield and replace him with Dr Dolphin. A source said: 'This shows the dominant ideological forces currently at play within the BMA. In order to get on, you have to embrace this way of thinking.' The BMA set up a rival 'task and finish group' to evaluate the methodology used by Cass and write a critique which they said would be completed by January. However, the report has still not been produced six months after the initial deadline and more than 1,000 members have now signed a letter calling on the union to 'abandon the pointless exercise'. Critics say the BMA is ill-equipped to match the rigour of the Cass review, which was published in April 2024, and describe the union's efforts as a 'waste of money and staff time'. Senior doctors warn that the BMA - which represents 190,000 doctors - has alienated itself, is 'no longer a democratic organisation' and has made itself 'irrelevant' after being taken over by 'ideologues and interest groups'. They highlight that the BMA leadership has consistently failed to select motions relating to the Cass Review at annual conferences, including that held in Liverpool this week, meaning gender-critical members are silenced. Meanwhile, topics including the Israel-Gaza conflict and climate change have been prioritised for debate. Fiona McAnena, director of campaigns at human rights charity Sex Matters, said Dr Dolphin's election as chair 'shows how gender ideology breaks previously respectable organisations'. She added: 'The Cass Review is a comprehensive, evidence-based report on so- called gender medicine for children by an independent paediatrician with impeccable credentials. 'Creating doubt around it without robust evidence is irresponsible, misleading, and not in the best interests of patients. 'We've said before that the transactivist doctors at the BMA are an embarrassment to their profession. 'Their false assertions about biology can be disproven with primary school science. 'Giving them this level of credibility could have serious consequences for the health and wellbeing of vulnerable children and young adults.' Dr Dolphin is a Labour activist who previously boasted of charging the NHS £1,870 for a single shift. He made the extortionate sum covering for picketing colleagues during previous industrial action and donated it to the BMA's strike fund. Writing on X at the time, he said the war chest 'supports people to strike, meaning the strike is stronger and the win will come sooner'. Dr Dolphin has campaigned alongside hard-left MP John McDonnell and been the election agent for Dawn Butler during previous general elections. He also finds time to promote woke cases, including trans issues and veganism. Writing on social media in 2019, Dr Dolphin said: 'This election has really got our membership engaged and working together to bring in a new, different, Labour government.' In July 2022, he posted photos of himself at a Trans Pride march, adding: 'About to set off to let London know that trans rights are human rights!' He has described Brexit as a 'failure' and 'one of the worst foreign policy decisions by the UK in decades'. The union this week passed a motion at its annual conference urging members to offer patients 'identity-based care', despite warnings this risks going against the law on single sex spaces. It follows the Supreme Court ruling in April that the terms woman and sex in the 2010 Equality Act 'refer to a biological woman and biological sex'. Dr Dolphin is an anaesthetic consultant, who has been a member of BMA council since 2012 and lives in London with his husband. He vowed to continue the union's fight for higher pay rises for doctors and said: 'I will empower BMA members so that everywhere that doctors work and medical students study, they know that they are stronger together, and the exploitation and erosion of our profession is stopped.' Commenting on delays to the union's Cass 'critique', a BMA spokeswoman said: 'The original draft Terms of Reference (ToR) that were shared with Council suggested that the Task and Finish Group would report back in January. 'This was removed whilst the ToR were still in draft and has therefore not been an objective for the project, but the Group's chair has continued to give updates to Council. 'This is an extremely complex report to undertake. 'We want to be as sure as we can be that data collection and analysis processes are as rigorous and robust as possible; this requires time, rather than be rushed.'
Daily Mail
an hour ago
- Daily Mail
Certain type of coffee linked to crippling eye disease as doctors warn: Stop drinking it, NOW
It already tastes significantly worse, but there might be an even bigger reason not to drink instant coffee. Chinese researchers say they have found a link between instant coffee and an eye disease that causes blurry or distorted central vision. They found that those with a preference for instant coffee were up to seven times more likely to develop the disorder than drinkers of other types. Known as age-related macular degeneration (AMD), it sees the small, central part of the retina wear down, affecting people's ability to read, drive and recognize faces. Researchers believe the link could be due to the way instant coffee is prepared, which releases a chemical called acrylamide which may enter the bloodstream and damage the retina. Dr Qi Jia, an ophthalmologist who led the study, warned: 'Instant coffee may increase the risk of age-related macular degeneration, and reducing its intake could help prevent[it]. 'People at high risk of age-related macular degeneration should avoid instant coffee.' People who have a family history of the disease, are overweight, smoke or have high blood pressure are all at higher risk for the condition. People with blue or green eyes are also at an elevated risk because their eyes contain less pigment, which means they can sustain more damage from sunlight. But the researchers caution their study was observational and does not prove that instant coffee causes AMD. Previous studies have actually shown that coffee could reduce the risk of AMD. A 2023 study involving 67,000 adults linked coffee drinking to a thickening of nerve fiber layers in the eye, helping to protect vision. However, the new study is one of the few to look at different types of coffee. The study used data on participants from the UK Biobank and the FinnGen consortium, which tracks genetic data on people in Britain and Finland. The study didn't strictly look at whether someone drank instant coffee, it used a different methodology involving genes. There is some evidence that people's genes decide which coffee they prefer, whether they prefer a more bitter or smoother taste and if they can easily tolerate caffeine. After dividing participants by their genetic predisposition for drinking instant, ground or decaffeinated coffee, they then analyzed the AMD rates. Results showed those placed in the instant coffee group were 692 percent more likely to be diagnosed with dry age-related macular degeneration — where the macula, in the center of the eye and responsible for central vision, deteriorates over time. They also said they were 159 percent more likely to suffer from wet age-related macular degeneration — where abnormal blood vessels grow under the macula, causing vision complications. Decaf drinkers were also found to be 80 percent more likely to suffer from dry AMD, although this difference was not significant. Participants were only considered to have developed AMD if it appeared after their 50th birthday and was diagnosed by a physician. AMD is a common condition among older adults, with approximately one in ten Americans aged 50 years or over suffering from the condition. There is no cure for the condition, but doctors say that starting treatment early can help to slow its progression. This may include taking supplements like vitamin C, E and zinc, or drugs for wet AMD that can slow the growth of blood vessels in the eyes. Researchers emphasize that more work is needed to confirm the findings of the study. Overall, it included 7,600 participants who had dry AMD and 5,900 who had wet AMD. It was published in the journal Food Science and Nutrition.
Telegraph
an hour ago
- Telegraph
How the BMA became a vessel for Middle East politics
There is slightly more to the Hippocratic Oath than many non-medical professionals realise. The full text contains all the well-known bits – do no harm, don't administer poison, maintain the confidentiality of your patients – but over the course of more than 300 words, there are also pledges about pessaries, kidney stones and dietary regimes. It is a broad, ancient expression of ethics for an industry that has to adapt and modernise all the time. The role of a medical professional, of course, touches on almost all aspects of life, so recent renderings of the oath might tinker with the translation a bit. Yet, what no version touches on, so far as we can tell, is anything to do with solving the conflict in the Middle East, a call to political activism, or prolonged discussions about Zionism. Attendees at the annual conference of the British Medical Association (BMA), the doctors' trade union, could have been forgiven for thinking otherwise this week. Meeting in Liverpool for three days to establish policies and priorities for the industry in the coming year – of which, given the state of the NHS, there would have been lots to discuss – members instead found that 43 motions, around 10 per cent of the total, related to Israel, Gaza, Palestine, anti-Semitism or Zionism. One claimed that Israel is establishing a 'system of apartheid', another called for a boycott of Israeli medical institutions and universities. A third called on the BMA to support doctors who refuse to pay taxes because the UK is 'complicit in genocide'. The slew of motions prompted the Jewish Medical Association (JMA) to warn that Jewish members attending the conference felt 'intimidated, unsafe and excluded'. Speaking anonymously for fear of reprisals, several other BMA members The Telegraph has spoken to were, at best, perplexed and exasperated so much attention was being paid to global politics ahead of matters relating to British medicine. Others saw it as typical of a union they view as 'institutionally anti-Semitic ', and now 'overtaken by Left-wing entryists'. 'It was a disappointing conference in lots of ways, especially in relation to how much time was given to talking about Gaza,' says one doctor and longstanding BMA member, after returning from Liverpool. 'There are so many other conflicts around the world where doctors and healthcare professionals are involved, so it seems a shame we didn't think about them as well. 'Also, because it was spoken about at such length, it stopped us getting on with some of the work I hoped we might have done as a trade union. And then there's the question of how welcome our Jewish colleagues might have felt, when there's so much emphasis given to a subject like that.' The answer to that final question can be given by Prof David Katz, professor of immunopathology at University College London, and executive chairman of the JMA, who also attended. 'In Liverpool, there was a hostility in the atmosphere,' Prof Katz says. 'How could it be otherwise with these motions? [With] the depth of venom that has been allowed to evolve?' Established in 1832, the BMA represents some 190,000 doctors and medical students across the UK, and lists its mission simply: 'We look after doctors so they can look after you'. Over its long history, it has occasionally taken stances on overseas conflicts, usually advocating for the safety of healthcare workers. Given the Israeli attacks on hospitals in Gaza, plus the reels of social media footage taken from inside those institutions, often by doctors, the conflict there is an understandably distressing one for BMA members – and has included acts the union would be expected to condemn. Critics, though, believe its interest is now neither balanced nor proportionate. 'When it [the union] used to stray into international issues, it did so with an equal hand,' says one retired GP, who was a BMA member for 45 years. '[But] it doesn't involve itself much now in Ukraine, or Sudan, or with the Uyghurs, or any other oppressed minority. It doesn't comment on US aid cuts. No, it is absolutely obsessed with the Palestinian cause.' It is, he alleges, a situation that has developed 'rapidly in the last four or five years, when the junior doctors committee [now known as the resident doctors committee] started to become very radical, and those making policy were very Left-wing. This was roughly at the end of the Corbyn years, when that sort of politics was becoming very mainstream.' Though it's often characterised as 'student politics' largely conducted online, the retired GP stresses that 'many of the very Left-wing older members are fully signed-up as well'. Just last week, the BMA was accused of a 'cover-up' when it dropped an investigation into its president, the highly experienced GP Dr Mary McCarthy, for social media posts about the Middle East conflict. Having initially decided there was a case for McCarthy to answer, after an independent review into a complaint by Labour Against Antisemitism, the BMA decided not to take it further because the issue had not been raised by a member or employee of the union. She is one of several BMA leaders who have had their online posts scrutinised. In 2023, Dr Martin Whyte, a paediatrician and then deputy co-chair of the BMA's junior doctors' committee, was suspended after joking online about 'gas[sing] the Jews', the 'holohoax', and writing that people should boycott Israel 'out of spite'. One London-based consultant – who was a BMA member until a year ago, when he was one of several doctors to resign his membership after the union published a controversial open letter to the Foreign Secretary urging the Government to call for an 'immediate ceasefire' in Gaza – claims the union is now practically run by its far-Left members. 'I was very fond of the BMA. My father was a doctor, his obituary was published in the British Medical Journal [owned by the BMA], but it seems to have been hijacked in the last few years. It's probably been under the surface for a long time, but they seem to prioritise things that aren't health-related.' he says. 'I would consider myself left-of-centre, but I don't really have a home in the BMA any more, and I think a lot of Jewish doctors feel that. The whole situation in the Middle East is tragic, I have every sympathy with Palestinians, as I do with the victims of October 7. But it's far from the only conflict going on in the world where innocent people are being killed, yet the BMA seems to have an obsession with the Palestinian issue, such that they are alienating a lot of Jewish doctors. They will end up having an organisation with very few Jewish doctors. And maybe some people in the BMA want that, I don't know. 'I can't really say exactly why they're so focused on Israel and Gaza, but it's a bit like the way that Jeremy Corbyn's Labour Party was. They just don't seem to have a neutral approach to it, which I find very sad, and it does smack of anti-Semitism, the way they seem to be quite obsessed with this particular issue. The fact is: the huge number of motions at the BMA conference [to do with Israel] means Jewish doctors don't feel that safe in the BMA. I'm talking to you anonymously, and I'm not even a member any more. It's just not a safe or friendly environment for Jewish doctors.' As it is, many Jewish members of the BMA are now resigning in protest. One letter, shared with The Telegraph, accuses the union of being 'institutionally anti-Semitic [and] unable to represent me fairly or safely' any more. 'As an adult and a professional, I expect to be represented by an organisation that engenders respect, and represents me with professionalism and gravitas in keeping with the serious responsibilities and obligations we as doctors have to our patients, our colleagues and the wider community,' the doctor writes. 'Being represented by a group of irresponsible militants playing dog whistle student politics, indulging in rank and toxic racism (in the form of Jew hatred) and infusing this old and venerable institution with both, is not something I am prepared to be associated with.' The BMA points out that one of the motions put forward in Liverpool this week specifically called for support for Jewish people, and was proposed by a Jewish medical student, who urged that members 'differentiate between pro-Palestinianism and anti-Semitism'. That said, quite how the BMA came to have its annual conference so dominated by geopolitics and activism – as one member put it, 'in the same week that Nato is meeting, has the BMA picked up the wrong agenda?' – is a question many members might recall asking last year, too. It was reported in 2024 that one in 10 motions put forward for the Belfast-hosted event had to be removed from debates on legal grounds because they related to the Israel and Palestine conflict, and 'risked being perceived as discriminatory, more specifically, anti-Semitic'. At the time, Prof Katz wrote to the BMA to say JMA members 'are deeply concerned that the meeting environment could become itself a vehicle for discrimination and Jew hatred.' A year on, members attending the BMA conference were met with not only another agenda with a heavy emphasis on the situation in the Middle East, but a protest staged by the activist group Health Workers 4 Palestine outside the venue in Liverpool. The demonstration featured 'old shoes' representing healthcare workers killed in Gaza – a visual statement synonymous with the shoes of Jewish people killed at concentration camps during the Holocaust, and considered anti-Semitic by the International Holocaust Remembrance Alliance. Inside, often hostile debates raged. Prof Katz, in attendance as ever, strode around attending as many as he could. A well-known figure at BMA conferences, he has never been shy to speak out about anti-Semitism in his profession, regardless of the crowd. One day this week, he says, he was having a quiet coffee when suddenly he had company. Sikh, Hindu and Christian colleagues in turn took seats next to him. 'We just wanted to make sure you didn't feel on your own here,' they told him. 'Under such circumstances,' Prof Katz says, 'small gestures count.' A BMA spokesperson said: 'We are totally clear that anti-Semitism is completely unacceptable. There is no place for it in the BMA, NHS, or wider society and we condemn anti-Semitism in the strongest possible terms, as we do with all discrimination based on race, religion, sexuality, gender or disability. 'The BMA's annual representative meeting is an inclusive space, where wellbeing of members and staff is our priority and we've put in place a number of measures and sources of support to ensure this. We are also confident that we are complying with all of our obligations under the Equality Act and our own EDI policies. 'The BMA has a long and proud history of advocating for human rights and access to healthcare around the world, and motions submitted to this year's conference by grassroots members from across the UK reflect the grave concerns doctors in the UK have about the Gaza conflict and the impact on civilians and healthcare. Resolutions passed at the conference made clear calls around the principles of medical neutrality and the need to respect international humanitarian law that are applicable to all conflicts. 'Motions were also submitted on the crises in Ukraine, Yemen, and Sudan, all of which the BMA has spoken out about and taken action on in recent years.'
